A randomised double-blind multi-site parallel arm controlled trial to assess relief of refractory breathlessness comparing fixed doses of morphine and placebo.

Data set includes individual participant data for 299 consenting participants. A total of 284 participants were randomised (145 to Morphine, 139 to Placebo, and a further 74 participants to the oxycodone arm. The oxycodone arm was later dropped due to recruitment difficulties). The data sets includes CSV files for screening and baseline, day 1 and day 7 outcome data, and 4 weeks of follow-up. Data is available for clincial investigations, demographic information, Functional assessment (AKPS and DES), Dyspnoea descriptors, Breathlessness scores (VAS, Likert, and mMRC), EORTC QLQ-C15, and Respiratory Disease Questionnaire, Global Impression of Change, Carer Quality of Life, Life Space Assessment, Health Service Utilisation, Symptoms and Adverse Events.